Trial Details
COMPLETEDBasic Information
| Clinical ID | c3499 |
|---|---|
| Identifier | NCT01951326 |
| Trial Title | Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: RHB-104|DRUG: Placebo |
Participant Information
| Sponsor | RedHill Biopharma Limited |
|---|---|
| City | Tucson |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2013-09 |
|---|---|
| Primary Completion Date | 2018-05 |
| Completion Date | 2019-08 |